Hence, it is generally thought that obesity shifts the ATM balance from M2 to a more M1 phenotype, and that anti-diabetic interventions, such as thiazolidinediones (TZDs), reverse this shift along with decreasing CD11c+ ATM numbers. The gene discussed is ITGAX; the disease is obesity due to melanocortin 4 receptor deficiency.